Literature DB >> 11934542

Circulating concentrations of soluble leptin receptor: influence of menstrual cycle and diet therapy.

Hiroyuki Shimizu1, Kenju Shimomura, Mayumi Negishi, Miki Masunaga, Yutaka Uehara, Noriyuki Sato, Yohnosuke Shimomura, Kikuo Kasai, Masatomo Mori.   

Abstract

Concentrations of the soluble leptin receptor (sOB-R) may be related to leptin resistance in obesity. We measured sOB-R concentrations in serum in 103 non-diabetic Japanese men and women. All subjects were grouped according to body mass index (BMI; in kg/m(2)). Serum sOB-R concentrations did not differ significantly between normal-weight (18.5 < or = BMI < 25.0) men and women, but were significantly higher in underweight subjects (BMI < 18.5) than in normal-weight subjects. In contrast, overweight (25 < or = BMI < 30) and obese (30 < or = BMI < 35.0, 35.0 < or = BMI < 40, and BMI > or = 40) subjects had significantly lower sOB-R concentrations than did normal-weight subjects. Serum sOB-R concentrations were inversely correlated with BMI and serum immunoreactive leptin concentrations. Very low-energy diet therapy for 4 wk significantly lowered serum immunoreactive leptin concentrations but did not significantly affect serum sOB-R concentrations. Serum sOB-R concentrations did not change significantly during the menstrual cycle. Our results showed that serum sOB-R concentrations decrease with increasing BMI and that sex hormones likely do not affect serum sOB-R concentrations in non-pregnant women. The reduction in serum sOB-R concentrations in overweight and obese persons may reflect downregulation of hypothalamic leptin receptor production as a result of an increase in circulating leptin and might be an important factor in leptin resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934542     DOI: 10.1016/s0899-9007(01)00787-0

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  6 in total

Review 1.  Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis.

Authors:  G Tian; J-N Liang; H-F Pan; D Zhou
Journal:  Ir J Med Sci       Date:  2014-02-09       Impact factor: 1.568

2.  Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome.

Authors:  Ru-Biao Liu; Yi Liu; Li-Qun Lv; Wei Xiao; Cheng Gong; Jian-Xin Yue
Journal:  Curr Med Sci       Date:  2019-07-25

3.  Reduced body weight and increased energy expenditure in transgenic mice over-expressing soluble leptin receptor.

Authors:  Phing-How Lou; Guoqing Yang; Lu Huang; Yunxia Cui; Tiffany Pourbahrami; George K Radda; Cai Li; Weiping Han
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

4.  Leptin as well as Free Leptin Receptor Is Associated with Polycystic Ovary Syndrome in Young Women.

Authors:  Nasser M Rizk; Elham Sharif
Journal:  Int J Endocrinol       Date:  2015-06-09       Impact factor: 3.257

5.  AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings.

Authors:  Irmina Olejniczak-Staruch; Joanna Narbutt; Justyna Ceryn; Małgorzata Skibińska; Igor Bednarski; Anna Woźniacka; Joanna Sieniawska; Marzena Kraska-Gacka; Magdalena Ciążyńska; Janusz Śmigielski; Marcin Noweta; Michał Waszczykowski; Witold Owczarek; Adam Reich; Aleksandra Lesiak
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

6.  Decreased serum level of soluble-leptin-receptor in patients with systemic lupus erythematosus.

Authors:  K Bagheri; P Ebadi; S Naeimi
Journal:  Iran Red Crescent Med J       Date:  2012-09-30       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.